In vitro analysis of expression vectors for DNA vaccination of horses: the effect of a Kozak sequence.

This research explores how different modifications to DNA vectors can enhance or reduce their expression in horse cells, which is crucial in the development of DNA vaccines for horses. A key finding is that adding a Kozak sequence boosts the gene expression in various types of horse cells.

Research Overview and Goal

• The study was centred on finding an efficient strategy for DNA vaccine development in horses, with a particular focus on expression vectors. Expression vectors are vehicles used to introduce foreign genes into the cells of a host organism.
• There’s been a focus on how vectors operate in horse cells, particularly in relation to the expression of the human serum albumin gene, which was being introduced ‘ectopically’ or outside its normal location.

Use of Different Types of Vectors

• Two types of vectors were employed – pcDNA and pUC – both with the cytomegalovirus (CMV) promoter, a commonly used promoter in research to boost gene expression.
• The differences between the vectors lay in the presence or absence of CMV intron A. The pUC vectors contained CMV intron A, whilst the pcDNA vectors did not.

Impact of Intron A and Kozak Sequence

• Their experiments revealed that the inclusion of intron A in the pUC vectors decreased expression derived from pcDNA vectors. Contrarily, the introduction of a Kozak sequence, which helps to initiate protein translation, significantly increased gene expression in the pUC vectors.
• This increase in expression was observed in horse cells derived from multiple tissue types, including the skin, lung, duodenum, and kidneys.

Key Findings and Significance

• The study highlighted the importance of the ‘full consensus’ Kozak sequence for protein expression in horse cells in vitro or under lab conditions for the very first time.
• These findings provide insights that could inform and improve the development processes for DNA vaccines for horses, potentially enabling the creation of better, more targeted treatments.